Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A25589 | 21682831 | Hepatol Res | Close correlation of liver stiffness with collagen deposition and presence of myofibroblasts in non-alcoholic fatty liver disease. | 2011 | Details |
| A25590 | 21679251 | J Gastroenterol Hepatol | Colorectal neoplasms in relation to non-alcoholic fatty liver disease in Korean women: a retrospective cohort study. | 2012 | Details |
| A25591 | 21678341 | Cochrane Database Syst Rev | Weight reduction for non-alcoholic fatty liver disease. | 2011 | Details |
| A25592 | 21677329 | Ann Hepatol | Pentoxifylline for the treatment of non-alcoholic steatohepatitis: a randomized controlled trial. | 2011 | Details |
| A25593 | 21675270 | Ter Arkh | [Clinical significance of intravital morphological investigation of the liver]. | 2011 | Details |
| A25594 | 21674556 | Hepatology | Role of ethnicity in overweight and obese patients with nonalcoholic steatohepatitis. | 2011 | Details |
| A25595 | 21674544 | Lasers Surg Med | Multi-excitation fluorescence spectroscopy for analysis of non-alcoholic fatty liver disease. | 2011 | Details |
| A25596 | 21674175 | Dig Dis Sci | Serum immunoglobulin a concentration is an independent predictor of liver fibrosis in nonalcoholic steatohepatitis before the cirrhotic stage. | 2011 | Details |
| A25597 | 21671974 | Scand J Immunol | Resistin is associated with breach of tolerance and anti-nuclear antibodies in patients with hepatobiliary inflammation. | 2011 | Details |
| A25598 | 21669571 | Hepatobiliary Pancreat Dis Int | Relationship between alcohol consumption and clinical manifestation of patients with fatty liver: a single-center study. | 2011 | Details |
| A25599 | 21669003 | BMC Gastroenterol | Discrimination of individuals in a general population at high-risk for alcoholic and non-alcoholic fatty liver disease based on liver stiffness: a cross section study. | 2011 | Details |
| A25600 | 21665509 | Diabetes Metab | Association of PNPLA3 SNP rs738409 with liver density in African Americans with type 2 diabetes mellitus. | 2011 | Details |
| A25601 | 21664615 | Atherosclerosis | Liver transcriptional profile of atherosclerosis-related genes in human nonalcoholic fatty liver disease. | 2011 | Details |
| A25602 | 21664213 | Clin Res Hepatol Gastroenterol | Increased expression of cytochrome P450 2E1 in nonalcoholic fatty liver disease: mechanisms and pathophysiological role. | 2011 | Details |
| A25603 | 21663607 | Lipids Health Dis | Lack of effect of apolipoprotein C3 polymorphisms on indices of liver steatosis, lipid profile and insulin resistance in obese Southern Europeans. | 2011 | Details |
| A25605 | 21659620 | Am J Physiol Gastrointest Liver Physiol | Role of integrins in fibrosing liver diseases. | 2011 | Details |
| A25606 | 21656912 | Proteomics Clin Appl | Utility of formalin-fixed, paraffin-embedded liver biopsy specimens for global proteomic analysis in nonalcoholic steatohepatitis. | 2011 | Details |
| A25607 | 21655948 | Dig Dis Sci | Mechanisms linking nonalcoholic fatty liver disease with coronary artery disease. | 2011 | Details |
| A25608 | 21654360 | Adv Anat Pathol | Update on fatty liver disease and steatohepatitis. | 2011 | Details |
| A25609 | 21651352 | Expert Rev Gastroenterol Hepatol | Animal models in the study of hepatitis C virus-associated liver pathologies. | 2011 | Details |
| A25610 | 21649947 | Ned Tijdschr Geneeskd | [Treatment of non-alcoholic fatty liver disease]. | 2011 | Details |
| A25611 | 21649732 | J Gastroenterol Hepatol | Susceptibility of rat non-alcoholic fatty liver to the acute toxic effect of acetaminophen. | 2012 | Details |
| A25612 | 21645964 | Ultrasound Med Biol | High-frequency ultrasound imaging for longitudinal evaluation of non-alcoholic fatty liver disease progression in mice. | 2011 | Details |
| A25613 | 21645445 | Zhonghua Gan Zang Bing Za Zhi | [General characteristics and clinical practices of Chinese patients with non-alcoholic fatty liver disease]. | 2011 | Details |
| A25614 | 21645344 | BMC Med | The role of lifestyle changes in the management of chronic liver disease. | 2011 | Details |
| A25615 | 21643627 | Mol Med Rep | Celecoxib attenuates liver steatosis and inflammation in non-alcoholic steatohepatitis induced by high-fat diet in rats. | 2011 | Details |
| A25616 | 21641054 | Int J Cardiol | Visceral abdominal adipose tissue and coronary atherosclerosis in asymptomatic diabetics. | 2011 | Details |
| A25617 | 21639814 | Expert Opin Pharmacother | Expert opinion on current therapies for nonalcoholic fatty liver disease. | 2011 | Details |
| A25618 | 21635880 | Clin Biochem | Serum galectin-3 levels in patients with nonalcoholic fatty liver disease. | 2011 | Details |
| A25619 | 21635548 | APMIS | Microvesicular fat, inter cellular adhesion molecule-1 and regulatory T-lymphocytes are of importance for the inflammatory process in livers with non-alcoholic steatohepatitis. | 2011 | Details |
| A25620 | 21634051 | Clin Res Hepatol Gastroenterol | Progression from isolated steatosis to steatohepatitis and fibrosis in nonalcoholic fatty liver disease. | 2011 | Details |
| A25622 | 21633658 | World J Gastroenterol | microRNAs: fad or future of liver disease. | 2011 | Details |
| A25623 | 21633525 | World J Gastroenterol | Mallory-Denk Bodies in chronic hepatitis. | 2011 | Details |
| A25624 | 21633178 | J Clin Invest | The role of lipid droplets in metabolic disease in rodents and humans. | 2011 | Details |
| A25625 | 21633093 | J Lipid Res | A role for miR-296 in the regulation of lipoapoptosis by targeting PUMA. | 2011 | Details |
| A25626 | 21631560 | Aliment Pharmacol Ther | Association between the presence of brown adipose tissue and non-alcoholic fatty liver disease in adult humans. | 2011 | Details |
| A25627 | 21629127 | J Pediatr Gastroenterol Nutr | Mechanisms of lipotoxicity in NAFLD and clinical implications. | 2011 | Details |
| A25628 | 21629037 | Am J Med Sci | Lipid targets during statin treatment in dyslipidemic patients affected by nonalcoholic fatty liver disease. | 2011 | Details |
| A25629 | 21626400 | J Physiol Biochem | Vitamin A and lipid metabolism: relationship between hepatic stellate cells (HSCs) and adipocytes. | 2011 | Details |
| A25630 | 21624329 | Zhonghua Yu Fang Yi Xue Za Zhi | [Effects of soybean isoflavone on liver lipid metabolism in nonalcoholic fatty liver rats]. | 2011 | Details |
| A25631 | 21623852 | Aliment Pharmacol Ther | Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. | 2011 | Details |
| A25632 | 23056785 | Iran J Pediatr | Risk Score Model for Predicting Sonographic Non-alcoholic Fatty Liver Disease in Children and Adolescents. | 2011 | Details |
| A25633 | 21621638 | Biochim Biophys Acta | Differential effects of short- and long-term high-fat diet feeding on hepatic fatty acid metabolism in rats. | 2011 | Details |
| A25634 | 21620948 | Toxicol In Vitro | Cellular glutathione in fatty liver in vitro models. | 2011 | Details |
| A25635 | 21620823 | Eur J Pharmacol | Osthol ameliorates fat milk-induced fatty liver in mice by regulation of hepatic sterol regulatory element-binding protein-1c/2-mediated target gene expression. | 2011 | Details |
| A25636 | 21618687 | Liver Transpl | Splenic artery embolization for the treatment of refractory ascites after liver transplantation. | 2011 | Details |
| A25639 | 21616061 | Biochem Biophys Res Commun | Soluble FGFR4 extracellular domain inhibits FGF19-induced activation of FGFR4 signaling and prevents nonalcoholic fatty liver disease. | 2011 | Details |
| A25640 | 21612324 | Drug Metab Rev | Drug metabolism alterations in nonalcoholic fatty liver disease. | 2011 | Details |
| A25641 | 21612059 | Vnitr Lek | [Steatosis and steatohepatitis in diabetic patient]. | 2011 | Details |
| A25642 | 21604917 | Ann Med | The Finnish Diabetes Risk Score (FINDRISC) as a screening tool for hepatic steatosis. | 2011 | Details |
| A25644 | 21602702 | J Clin Gastroenterol | Hepatic lipid peroxidation and cytochrome P-450 2E1 in pediatric nonalcoholic fatty liver disease and its subtypes. | 2011 | Details |
| A25645 | 21602530 | Gut | Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease. | 2011 | Details |
| A25646 | 21600867 | Clin Res Hepatol Gastroenterol | Diagnostic challenges of nonalcoholic fatty liver disease (NAFLD) in children of normal weight. | 2011 | Details |
| A25647 | 21599535 | Crit Rev Biochem Mol Biol | Insulin signaling to hepatic lipid metabolism in health and disease. | 2011 | Details |
| A25648 | 21598007 | Obes Surg | Clinical predictors of different grades of nonalcoholic fatty liver disease. | 2012 | Details |
| A25649 | 21596453 | Diabetes Res Clin Pract | Serum FGF21 levels are increased in newly diagnosed type 2 diabetes with nonalcoholic fatty liver disease and associated with hsCRP levels independently. | 2011 | Details |
| A25650 | 21595271 | Nihon Rinsho | [Attenuation of fatty accumulation in hepatocyte by incretin--expectation of novel medicine for treatment of NASH]. | 2011 | Details |
| A25651 | 21593806 | Obesity (Silver Spring) | Downregulation of hepatic glucose-6-phosphatase-α in patients with hepatic steatosis. | 2011 | Details |
| A25652 | 21592363 | Lipids Health Dis | α-Linolenic acid prevents endoplasmic reticulum stress-mediated apoptosis of stearic acid lipotoxicity on primary rat hepatocytes. | 2011 | Details |
| A25653 | 21587068 | Curr Opin Clin Nutr Metab Care | The 5-lipoxygenase/leukotriene pathway in obesity, insulin resistance, and fatty liver disease. | 2011 | Details |
| A25654 | 21585409 | Aliment Pharmacol Ther | Validation of the non-alcoholic fatty liver disease activity score. | 2011 | Details |
| A25655 | 21577310 | World J Gastrointest Pharmacol Ther | Is there any progress in the treatment of non-alcoholic fatty liver disease? | 2011 | Details |
| A25656 | 21576832 | Intern Med | The development of chronic kidney disease in Japanese patients with non-alcoholic fatty liver disease. | 2011 | Details |
| A25657 | 21570964 | Exp Mol Pathol | A novel cystine based antioxidant attenuates oxidative stress and hepatic steatosis in diet-induced obese mice. | 2011 | Details |
| A25658 | 21570653 | Eur J Intern Med | Alterations in lipid, carbohydrate and iron metabolism in patients with non-alcoholic steatohepatitis (NASH) and metabolic syndrome. | 2011 | Details |
| A25659 | 21570483 | Clin Gastroenterol Hepatol | Patients with NASH and cryptogenic cirrhosis are less likely than those with hepatitis C to receive liver transplants. | 2011 | Details |
| A25660 | 21569626 | Lipids Health Dis | Exercise and spirulina control non-alcoholic hepatic steatosis and lipid profile in diabetic Wistar rats. | 2011 | Details |
| A25661 | 21569072 | Clin Endocrinol (Oxf) | Long-term metformin treatment is able to reduce the prevalence of metabolic syndrome and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome. | 2011 | Details |
| A25662 | 21567402 | J Cell Physiol | Free fatty acids induce transglutaminase 2-dependent apoptosis in hepatocytes via ER stress-stimulated PERK pathways. | 2012 | Details |
| A25663 | 21565984 | J Appl Physiol (1985) | Does physical inactivity cause nonalcoholic fatty liver disease? | 2011 | Details |
| A25664 | 21565756 | Orv Hetil | [Clinical correlations of chronic hepatitis C, diabetes mellitus and steatohepatitis]. | 2011 | Details |
| A25665 | 21565479 | Nutr Metab Cardiovasc Dis | Management of metabolic syndrome in children and adolescents. | 2011 | Details |
| A25666 | 21564529 | Am J Transplant | Should metformin be our antiglycemic agent of choice post-transplantation? | 2011 | Details |
| A25668 | 21563774 | J Proteome Res | A proton nuclear magnetic resonance metabonomics approach for biomarker discovery in nonalcoholic fatty liver disease. | 2011 | Details |
| A25669 | 21563648 | Acta Gastroenterol Belg | High prevalence of advanced fibrosis in association with the metabolic syndrome in a Belgian prospective cohort of NAFLD patients with elevated ALT. Results of the Belgian NAFLD registry. | 2011 | Details |
| A25670 | 21563361 | Eksp Klin Gastroenterol | [Advisability of using probiotics in the treatment of atherogenic dyslipidemia]. | 2011 | Details |
| A25671 | 21562784 | Dig Dis Sci | Fatty liver is associated with recurrent bacterial infections independent of metabolic syndrome. | 2011 | Details |
| A25672 | 21562757 | Diabetologia | Osteopontin deficiency protects against obesity-induced hepatic steatosis and attenuates glucose production in mice. | 2011 | Details |
| A25673 | 21561340 | Metab Syndr Relat Disord | Oxidative stress is activated by free fatty acids in cultured human hepatocytes. | 2011 | Details |
| A25674 | 21561285 | Scand J Gastroenterol | Overweight and hypertriglyceridemia are risk factors for liver cirrhosis in middle-aged Swedish men. | 2011 | Details |
| A25675 | 21560640 | Eksp Klin Gastroenterol | [Gastroenterological aspects of atherosclerosis]. | 2011 | Details |
| A25676 | 21559749 | Intern Emerg Med | Is nonalcoholic steatohepatitis associated with a high-though-normal thyroid stimulating hormone level and lower cholesterol levels? | 2011 | Details |
| A25677 | 21559737 | Dig Dis Sci | Focal fat masquerading as malignancy in the liver graft of a post-transplant patient. | 2011 | Details |
| A25678 | 21557768 | J Gastroenterol Hepatol | Non-invasive estimation of liver fibrosis in non-alcoholic fatty liver disease using the 13 C-caffeine breath test. | 2011 | Details |
| A25680 | 21557024 | Hepatol Int | Clinical significance of serum autoantibodies in patients with NAFLD: results from the nonalcoholic steatohepatitis clinical research network. | 2011 | Details |
| A25681 | 21556019 | Nat Rev Endocrinol | Nonalcoholic fatty liver disease and diabetes mellitus: pathogenesis and treatment. | 2011 | Details |
| A25682 | 21549692 | Eur J Pharmacol | Effects of bezafibrate in nonalcoholic steatohepatitis model mice with monosodium glutamate-induced metabolic syndrome. | 2011 | Details |
| A25683 | 21549113 | Eur J Pharmacol | Pentoxifylline and melatonin in combination with pioglitazone ameliorate experimental non-alcoholic fatty liver disease. | 2011 | Details |
| A25684 | 21547049 | J Ayurveda Integr Med | A study of standardized extracts of Picrorhiza kurroa Royle ex Benth in experimental nonalcoholic fatty liver disease. | 2010 | Details |
| A25685 | 21546603 | Arterioscler Thromb Vasc Biol | Hepatic steatosis, obesity, and the metabolic syndrome are independently and additively associated with increased systemic inflammation. | 2011 | Details |
| A25686 | 21545576 | Br J Pharmacol | Resistin: functional roles and therapeutic considerations for cardiovascular disease. | 2012 | Details |
| A25687 | 21543214 | J Nutr Biochem | Maternal high-fat feeding through pregnancy and lactation predisposes mouse offspring to molecular insulin resistance and fatty liver. | 2011 | Details |
| A25688 | 21543212 | J Nutr Biochem | Green tea extract protects against nonalcoholic steatohepatitis in ob/ob mice by decreasing oxidative and nitrative stress responses induced by proinflammatory enzymes. | 2011 | Details |
| A25691 | 21538280 | Semin Liver Dis | Genetics of alcoholic and nonalcoholic fatty liver disease. | 2011 | Details |
| A25692 | 21537547 | Arq Gastroenterol | Methionine- and choline-deficient diet induces hepatic changes characteristic of non-alcoholic steatohepatitis. | 2011 | Details |
| A25694 | 21535445 | Aliment Pharmacol Ther | Liver stiffness measurement by magnetic resonance elastography is not associated with developing hepatocellular carcinoma in subjects with compensated cirrhosis. | 2011 | Details |
| A25695 | 21534339 | Turk J Pediatr | Abdominal obesity is an independent risk factor for increased carotid intima- media thickness in obese children. | 2011 | Details |
| A25696 | 21530275 | Bioorg Med Chem | Structure-based design, synthesis, and nonalcoholic steatohepatitis (NASH)-preventive effect of phenylpropanoic acid peroxisome proliferator-activated receptor (PPAR) α-selective agonists. | 2011 | Details |
| A25697 | 21529810 | Atherosclerosis | PPARα activation differently affects microparticle content in atherosclerotic lesions and liver of a mouse model of atherosclerosis and NASH. | 2011 | Details |
| A25699 | 21525818 | Med Sci Monit | SIRT1 as a potential therapeutic target for treatment of nonalcoholic fatty liver disease. | 2011 | Details |